Join to View Full Profile
UW Highland Ave# 600Madison, WI 53792
Phone+1 608-263-6400
Dr. Sharifi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Marina Sharifi, MD is an Oncologist based in Madison, WI, specializing in Breast Cancer. She completed her residency in Internal Medicine (2016-2018) and her fellowship in Medical Oncology (2018-2022) at the University of Wisconsin Hospitals and Clinics. She is an alumna of University of Chicago Division of the Biological Sciences The Pritzker School of Medicine in 2016.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2018 - 2022- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2016 - 2018
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2016
Certifications & Licensure
WI State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer.Marina N Sharifi, Eric Feng, Nicholas R Rydzewski, Amy K Taylor, Jamie M Sperger
Molecular Oncology. 2025-02-22 - High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.Marina N Sharifi, Jamie M Sperger, Amy K Taylor, Katharine E Tippins, Shannon R Reese
Cancer Discovery. 2025-02-06 - Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey-Holden Prostate Cancer Academy Meeting.Andrea K Miyahira, Marina Sharifi, Lisa N Chesner, Asmaa El-Kenawi, Roni Haas
The Prostate. 2025-02-01
Journal Articles
- Functions of Autophagy in the Tumor Microenvironment and Cancer MetastasisErin E Mowers, Marina N Sharifi, The FEBS Journal
Press Mentions
Emerging Therapies Underscore Need for Genomic Testing in HR+/HER2– Breast CancerNovember 9th, 2023- Wisconsin Partnership Program Awards $1.2 Million Through New Investigator ProgramMarch 28th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
